Detalhe da pesquisa
1.
Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
Bioorg Chem
; 147: 107325, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38583247
2.
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition.
J Inorg Biochem
; 256: 112574, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677004
3.
Fighting metallodrug resistance through alteration of drug metabolism and blockage of autophagic flux by mitochondria-targeting AIEgens.
Chem Sci
; 13(5): 1428-1439, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35222927
4.
Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.
J Inorg Biochem
; 226: 111653, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740039
5.
Pediatric Clinical Trials in Mainland China Over the Past Decade (From 2009 to 2020).
Front Med (Lausanne)
; 8: 745676, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671625